文献速递艾滋病与性传播感染

接受抗逆转录病毒治疗的HIV成人患者脂肪量进行性增加,但性别与解剖部位模式不同

Progressive increases in fat mass occur in adults living with HIV on antiretroviral therapy, but patterns differ by sex and anatomic depot.
PubMed 文献 · J Antimicrob Chemother · 2019-01-01

研究纳入Modena HIV代谢门诊839名女性和1759名男性HIV感染者,每6-12个月行DXA扫描,中位随访4.6年。两性躯干和腿部脂肪均持续增加,男性年增幅高于女性;女性、每年ART使用(尤其TDF和INSTI)、BMI升高、无自报体力活动及CD4最低值<200 cells/mm3与脂肪量增加相关。

要点

  • 接受ART的HIV成人躯干和腿部脂肪随随访持续增加,男性年增幅高于女性
  • 女性、每年ART使用(尤其TDF和INSTI)、BMI升高、无体力活动及CD4最低值<200 cells/mm3与脂肪量增加相关
  • 临床应关注ART期间脂肪分布变化,尤其女性及低CD4最低值者

核心结论

  • 在接受ART的HIV感染者中,躯干和腿部脂肪量在中位4.6年随访期间持续增加,尤其女性;控制传统危险因素后,HIV和ART相关危险因素显现。

研究设计与样本

  • Modena HIV代谢门诊的男性和女性HIV感染者每6-12个月接受DXA扫描,最长10年,中位4.6年。
  • 839名女性和1759名男性贡献两次及以上DXA扫描。
  • 基线中位年龄44岁,BMI 22.9 kg/m2,76%基线时ART下病毒学抑制。

主要发现

  • 两性躯干和腿部脂肪在研究期间持续增加。
  • 女性躯干和腿部脂肪年均增加分别为3.6%和7.5%,男性分别为6.3%和10.8%。
  • 多因素分析中与更高脂肪量相关的因素包括女性、每年ART使用(尤其TDF和INSTI)、每单位BMI增加、无自报体力活动及CD4最低值<200 cells/mm3。

临床怎么用

  • 对接受ART的HIV感染者应关注脂肪量进行性增加,尤其女性及CD4最低值<200 cells/mm3者。
  • 使用TDF或INSTI方案及无体力活动者可能需加强体重和体脂监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Although weight gain on ART is common, the long-term trajectory of and factors affecting increases in fat mass in people living with HIV are not well described. METHODS: Men and women living with HIV in the Modena HIV Metabolic Clinic underwent DXA scans every 6-12 months for up to 10 years (median 4.6 years). Regression modelling in both combined and sex-stratified models determined changes in and clinical factors significantly associated with trunk and leg fat mass over the study period. RESULTS: A total of 839 women and 1759 men contributed two or more DXA scans. The baseline median age was 44 years and BMI 22.9 kg/m2; 76% were virologically suppressed on ART at baseline. For both sexes, trunk and leg fat consistently increased over the study period, with mean yearly trunk and leg fat gain of 3.6% and 7.5% in women and 6.3% and 10.8% in men, respectively. In multivariate analysis, factors associated with greater fat mass included female sex, per-year ART use (specifically tenofovir disoproxil fumarate and integrase strand transfer inhibitor therapy), per-unit BMI increase, no self-reported physical activity and CD4 nadir <200 cells/mm3. CONCLUSIONS: Among people living with HIV on ART, trunk and leg fat mass increased steadily over a median of 4.6 years of follow up, particularly among women. After controlling for traditional risk factors, HIV- and ART-specific risk factors emerged.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Debroy P, Sim M, Erlandson KM, et al. Progressive increases in fat mass occur in adults living with HIV on antiretroviral therapy, but patterns differ by sex and anatomic depot. J Antimicrob Chemother. 2019. PMID: 30668716. doi:10.1093/jac/dky551

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。